[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100335082":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":89,"collaborators":10,"id":91,"slug":10,"hasResults":92,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":96,"eligibilityCriteria":97,"healthyVolunteers":92,"sex":98,"minAge":99,"maxAge":10,"enrollmentInfo":100,"targetDuration":10,"studyType":103,"phases":10,"briefSummary":104,"conditions":105,"keywords":10,"overallStatus":59,"whyStopped":10,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Nīmes","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Patients with rheumatoid polyarthritis",null,[12],"Other: Questionnaire",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"Questionnaire","Patients are asked to complete several questionnaires",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Cécile Gaujoux Viala, MD","CONTACT","04 66 68 31 20","cecile.gaujoux.viala@chu-nimes.fr",[25,43,57,74],{"facility":26,"status":27,"city":28,"state":10,"zip":29,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"CHU Bordeaux","NOT_YET_RECRUITING","Bordeaux","33000","France",{"type":32,"coordinates":33},"Point",[34,35],-0.58046,44.84124,{"lat":35,"lon":34},[38,41],{"name":39,"role":21,"phone":10,"phoneExt":10,"email":40},"Christophe Richez, MD","christophe.richez@chu-bordeaux.fr",{"name":39,"role":42,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"facility":44,"status":27,"city":45,"state":10,"zip":46,"country":30,"cosmosGeoPoint":47,"geoPoint":51,"contacts":52},"CHRU Montpellier","Montpellier","34295",{"type":32,"coordinates":48},[49,50],3.87635,43.61093,{"lat":50,"lon":49},[53,56],{"name":54,"role":21,"phone":10,"phoneExt":10,"email":55},"Jacques Morel, MD","j-morel@chu-montpellier.fr",{"name":54,"role":42,"phone":10,"phoneExt":10,"email":10},{"facility":58,"status":59,"city":60,"state":10,"zip":61,"country":30,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"CHU Nimes","RECRUITING","Nîmes","30029",{"type":32,"coordinates":63},[64,65],4.35788,43.83665,{"lat":65,"lon":64},[68,72],{"name":69,"role":21,"phone":70,"phoneExt":10,"email":71},"Anissa Megzari","04.66.68.42.36","drc@chu-nimes.fr",{"name":73,"role":42,"phone":10,"phoneExt":10,"email":10},"Cécile Gaujoux Viala",{"facility":75,"status":27,"city":76,"state":10,"zip":77,"country":30,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"CHU Toulouse","Toulouse","31300",{"type":32,"coordinates":79},[80,81],1.44367,43.60426,{"lat":81,"lon":80},[84,87],{"name":85,"role":21,"phone":10,"phoneExt":10,"email":86},"Arnaud Constantin","arnaud.constantin@univ-tlse3.fr",{"name":88,"role":42,"phone":10,"phoneExt":10,"email":10},"Arnaud Constantin, MD",{"type":90,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100335082",false,"NCT03642795","Validation of the French Version of the CQR (Compliance Questionnaire Rheumatology)","Validation of the French Version of the CQR (Compliance Questionnaire Rheumatology): Specific Tool for Evaluation of Observance of Rheumatology Treatment","CQR-F","Inclusion Criteria:\n\n* The patient must have given their free and informed consent and signed the consent form\n* The patient must be a member or beneficiary of a health insurance plan\n* The patient is at least 18 years old\n* The patient has rheumatoid polyarthritis as defined by the ACR-EULAR 2010 criteria, treated orally or subcutaneously with MTX for at least 3 months with a stable (unchanged) dosage for at least 1 month, and a stable (unchanged) route of administration for at least 1 month. And no planned change in Methotrexate intake at least until the second study visit. Other treatments at the same time are authorized\n\nExclusion Criteria:\n\n* The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study\n* The subject refuses to sign the consent\n* It is impossible to give the subject informed information\n* The patient is under safeguard of justice or state guardianship\n* The subject has a contraindication to taking methotrexate (including a patient with a desire to become pregnant).","ALL","18 Years",{"count":101,"type":102},150,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to develop a French language version of the Compliance-Questionnaire-Rheumatology for use in French and Francophone rheumatology services",[106],"Rheumatoid Polyarthritis","2025-11-25",{"date":109,"type":110},"2025-12-03","ACTUAL",{"date":112,"type":110},"2022-06-23",{"date":114,"type":102},"2029-03",{"name":5,"class":6},4]